Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind placebo-controlled study of inhaled LQ036 in uncontrolled asthma
CTR20253131Phase 2Active
- Sponsor
- Novamab Biopharmaceuticals
- Start
- Nov 2025
- Modality
- Nanobodies (VHH) → Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of LQ036 in asthma, sponsored by Novamab Biopharmaceuticals. Started Nov 2025; status: active.
02
Drugs
LQ036
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20253131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253131.